Correction to: Peeling Skin Syndrome Type 1: Dupilumab Reduces IgE, But Not Skin Anomalies.

Autor: Barranca A; Dermatology Department, Reference Center for Rare Skin Diseases, Paul Sabatier University, Larrey Hospital, 24 Chemin de Pouvourville, 31059 Cedex 09, Toulouse, France., Jonca N; Infinity, Inserm - CNRS - UPS, Toulouse, France., Martin-Blondel A; Pediatric Pneumology and Allergology Center, Children's Hospital, 330 avenue de Grande‑Bretagne, 31059 Cedex 09, Toulouse, France., Apoil PA; Federal Institute of Biology, CHU de Toulouse, Toulouse, France.; UMR 1056 INSERM, Hôpital Purpan, Toulouse, France., Mazereeuw-Hautier J; Dermatology Department, Reference Center for Rare Skin Diseases, Paul Sabatier University, Larrey Hospital, 24 Chemin de Pouvourville, 31059 Cedex 09, Toulouse, France. mazereeuw-hautier.j@chu-toulouse.fr.
Jazyk: angličtina
Zdroj: Journal of clinical immunology [J Clin Immunol] 2022 Nov; Vol. 42 (8), pp. 1810.
DOI: 10.1007/s10875-022-01309-2
Databáze: MEDLINE